Newsroom
Latest News
WASHINGTON, D.C.– U.S. Rep. Diana DeGette's request for $2 million in federal funds to help the city of Denver purchase the now-vacant Stay Inn Hotel in Denver and convert it into housing for the homeless cleared a significant legislative hurdle Monday and is now one step closer to being approved.
On Monday, a key House Appropriations subcommittee approved a multi-billion-dollar housing bill that will, among other things, fund various housing projects across the country.
A Cold War-era Pentagon office credited with many scientific breakthroughs would be the model for a new government agency tasked with solving health's greatest mysteries if President Joe Biden and a Colorado congresswoman have their way.
Welcome to DC Doings, a weekly look at the Colorado congressional delegation's activity.
The House was in session for four days this week while the Senate was on a state work week. The Senate returns on July 12 following the one-week Fourth of July recess, and both chambers will be in session for the week of July 19.
Biden signs DeGette's methane resolution
President Joe Biden signed legislation sponsored by Democratic Rep. Diana DeGette on June 30 to reinstate rules restricting methane emissions at oil and gas drilling sites.
WASHINGTON, D.C. – The U.S. House of Representatives voted today to approve a massive infrastructure bill that includes, among other things, nearly $20 million for three critical transportation projects in the downtown Denver area.
The legislation - known as the INVEST in America Act – will provide the Colorado Department of Transportation, Denver Department of Transportation, and Denver's Regional Transportation District a combined $20 million to help realign I-25, make necessary improvements to Denver's light rail and revitalize the 16th Street Mall.
WASHINGTON, DC – President Biden signed into law today a Resolution of Disapproval to invalidate the Trump administration's 2020 Methane Rescission Rule and reinstate two key Obama-era methane-emission rules that set stricter limits on the amount of methane that the nation's oil and gas industry can release from their drilling sites.
WASHINGTON, DC – The U.S. House of Representatives voted today to approve a Resolution of Disapproval that will invalidate the Trump administration's 2020 Methane Rescission Rule – a move that will reinstate two key Obama-era methane-emission rules and reestablish stricter regulations on the nation's oil and gas industry.
Congressional Democrats have approved a measure reinstating rules aimed at limiting climate-warming greenhouse gas emissions from oil and gas drilling, a rare effort by Democrats to use the legislative branch to overturn a regulatory rollback under President Donald Trump.
The House gave final legislative approval Friday to a resolution that would undo a Trump-era environmental rule that relaxed requirements of a 2016 Obama administration rule targeting methane emissions from leaks and flares in oil and gas wells.
Congressional Democrats have approved a measure reinstating rules aimed at limiting climate-warming greenhouse gas emissions from oil and gas drilling, a rare effort by Democrats to use the legislative branch to overturn a regulatory rollback under President Donald Trump.
The House gave final legislative approval Friday to a resolution that would undo a Trump-era environmental rule that relaxed requirements of a 2016 Obama administration rule targeting methane emissions from leaks and flares in oil and gas wells.
U.S. Reps. Diana DeGette (D-CO) and Larry Bucshon, M.D. (R-IN) reintroduced bipartisan legislation today to improve the nation's diagnostic testing capabilities and ensure hospitals and laboratories across the country are better able to respond to future national health emergencies, such as the COVID-19 pandemic.
A bipartisan, bicameral group is reintroducing tweaked legislation Thursday that would overhaul how the FDA oversees laboratory-developed tests and diagnostics, POLITICO's David Lim reports.
The VALID Act would regulate both lab tests and diagnostics under a new framework clarifying the responsibilities of the FDA and CMS. Reps. Larry Bucshon (R-Ind.) and Diana DeGette (D-Colo.) are backing the bill in the House, with Sens. Michael Bennet (D-Colo.) and Richard Burr (R-N.C.) sponsoring the Senate version.